Pfizer MVC 300 (Selzentry 300 mg)
Generic Name: maraviroc
Pill imprint Pfizer MVC 300 has been identified as Selzentry 300 mg.
Selzentry is used in the treatment of hiv infection and belongs to the drug class chemokine receptor antagonist. There is no proven risk in humans during pregnancy. Selzentry 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Pfizer MVC 300
- 300 mg
- 12.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Chemokine receptor antagonist
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about Selzentry (maraviroc)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.